Mesenteric ischemia medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Mesenteric ischemia}}
 
{{CMG}} {{AE}} {{FT}}
{{CMG}} {{AE}} {{FT}}
==Overview==
==Overview==
Line 11: Line 11:
*Empiric therapy for [disease name] depends on [disease factor 1] and [disease factor 2].
*Empiric therapy for [disease name] depends on [disease factor 1] and [disease factor 2].
*Patients with [disease subclass 1] are treated with [therapy 1], whereas patients with [disease subclass 2] are treated with [therapy 2].
*Patients with [disease subclass 1] are treated with [therapy 1], whereas patients with [disease subclass 2] are treated with [therapy 2].
{| class="wikitable"
! colspan="6" |Multimodal management of mesenteric ischemia
|-
| colspan="4" |Early management
|Late management
|
|-
|Vascular occlusion
|Splanchnic hypoperfusion
|Intestinal hypoxia
|
* Intestinal barrier injury
* Translocation
* Local inflammatory pathway
|Systemic inflammatory pathways
|Necrosis
Organ failure
|-
|
* Heparin
* Aspirin
* Revascularization
| colspan="2" |
* Oxygen
* Blood volume resuscitation
* Transfusion
|
|Intravenous antibiotics
|Intestinal resection
|}
===Disease Name===
===Disease Name===
{{Reflist|2}}
{{Reflist|2}}


[[Category:Needs content]]
[[Category:Needs content]]

Revision as of 03:34, 18 December 2017


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Feham Tariq, MD [2]

Overview

Acute mesenteric artery ischemia is an emergency.Thrombolytics may be required to dissolve the clot, and vasodilators may be needed to widen the mesenteric arteries (vasodilators). Further treatment with surgery may still be required.

Medical Therapy

  • Pharmacologic medical therapy is recommended among patients with [disease subclass 1], [disease subclass 2], and [disease subclass 3].
  • Pharmacologic medical therapies for [disease name] include (either) [therapy 1], [therapy 2], and/or [therapy 3].
  • Empiric therapy for [disease name] depends on [disease factor 1] and [disease factor 2].
  • Patients with [disease subclass 1] are treated with [therapy 1], whereas patients with [disease subclass 2] are treated with [therapy 2].
Multimodal management of mesenteric ischemia
Early management Late management
Vascular occlusion Splanchnic hypoperfusion Intestinal hypoxia
  • Intestinal barrier injury
  • Translocation
  • Local inflammatory pathway
Systemic inflammatory pathways Necrosis

Organ failure

  • Heparin
  • Aspirin
  • Revascularization
  • Oxygen
  • Blood volume resuscitation
  • Transfusion
Intravenous antibiotics Intestinal resection

Disease Name